Current methods for cancer detection often involve invasive procedures or expensive imaging techniques, leading to delays in diagnosis and increased patient anxiety. The need for frequent monitoring, especially for individuals at high risk or those undergoing treatment, further exacerbates these challenges.

OncoRedox is developing a non-invasive cancer detection system that analyzes urine samples using electrochemical sensors to identify redox metabolic signatures associated with malignancy. The technology aims to provide a rapid, cost-effective, and convenient method for early cancer screening and monitoring. By detecting subtle changes in redox activity, the device offers the potential for earlier diagnosis, enabling timely intervention and improved patient outcomes. The system is designed to be easily integrated into routine checkups, facilitating frequent and accessible cancer monitoring.

Electrochemical sensors for detecting redox metabolic signatures in urine samples

Non-invasive and convenient sample collection

Rapid analysis and result generation

Potential for early cancer detection and monitoring

Cost-effective screening solution

The primary target audience includes healthcare providers, oncologists, and individuals at high risk for cancer, as well as those undergoing cancer treatment.